跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Calpol - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Calpol
Approved
STANDARD
Calpol
PT Glaxo Wellcome Indonesia
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
cfc42998a832cdd7
Company
PT Glaxo Wellcome Indonesia
Type
Standard
Approval Details
Approval Id
cfc42998a832cdd7
Drug Approval Philippines Name
Calpol
Product Name
Calpol
Registration Number
DR-XY47299
Brand Name
Calpol
Generic Name
Paracetamol
Dosage Form
Suspension (Oral Drops) (Orange Flavor)
Dosage Strength
100mg/mL
Manufacturer
PT Glaxo Wellcome Indonesia
Importer
GlaxoSmithKline Consumer Healthcare Philippines, Inc.
Issuance Date
26 July 2021
Expiry Date
17 June 2026
Pharmacologic Category
Analgesic/Antipyretic
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
cfc42998a832cdd7
Type
Standard
Back to Philippines FDA Approvals